Related Experiment Video
Updated: Jan 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Ganoderma triterpenes Protect Against Hyperhomocysteinemia Induced Endothelial-Mesenchymal Transition via TGF-β
Jinzhao He1, Yi Sun1, Yingli Jia1
1Key Laboratory of Molecular Cardiovascular Sciences, State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China.
Insights
Hyperhomocysteinemia causes endothelial-mesenchymal transition (EndMT) by activating key signaling pathways. Ganoderma triterpenes (GT) show protective effects against this process by reducing oxidative stress and inhibiting these pathways.
Area of Science:
- Cardiovascular Biology
- Cellular Mechanisms
- Pharmacology
Background:
- Endothelial dysfunction is a critical factor in cardiovascular diseases linked to hyperhomocysteinemia (HHcy).
- The precise mechanisms of HHcy-induced endothelial injury and effective treatments remain unclear.
- Endothelial-mesenchymal transition (EndMT) is implicated in HHcy-related pathologies.
Purpose of the Study:
- To investigate the mechanisms underlying HHcy-induced endothelial injury.
- To explore the protective potential of Ganoderma triterpenes (GT) against HHcy-induced endothelial damage.
- To elucidate the signaling pathways involved in HHcy-induced EndMT.
Main Methods:
- Utilized bovine aortic endothelial cells (BAECs) as an in vitro model.
- Employed small molecular inhibitors to probe signaling pathways (TGF-β/Smad, PI3K/AKT, MAPK).
- Assessed the effects of Ganoderma triterpenes (GT) on HHcy-induced EndMT, oxidative stress, and pathway activation.
Main Results:
- Hyperhomocysteinemia (HHcy) induced endothelial-mesenchymal transition (EndMT) in BAECs.
- Activation of TGF-β/Smad, PI3K/AKT, and MAPK signaling pathways was observed during HHcy-induced EndMT.
- Ganoderma triterpenes (GT) inhibited HHcy-induced EndMT by reducing oxidative stress and suppressing these signaling pathways, including Snail activity.
Conclusions:
- HHcy induces EndMT through the activation of TGF-β/Smad, PI3K/AKT, and MAPK pathways.
- Ganoderma triterpenes (GT) demonstrate therapeutic potential for HHcy-induced EndMT.
- GT alleviates oxidative stress and inhibits key signaling pathways, offering a novel treatment strategy.
Abstract:
Endothelial dysfunction is one of the most important pathological status in hyperhomocysteinemia (HHcy) related cardiovascular diseases. Whereas, the underlying mechanisms have not been fully elucidated yet, concomitant with the absence of effective treatment. The purpose of this study was to explore the main mechanisms involved in HHcy-induced endothelial injury and identify the protective effect of Ganoderma triterpenes (GT). Bovine aortic endothelial cells (BAECs) were applied as in vitro experimental model. The small molecular inhibitors were used to explore the signalings involved in HHcy-induced endothelial injury. The experimental results provided initial evidence that HHcy led to endothelial-mesenchymal transition (EndMT). Meanwhile, TGF-β/Smad, PI3K/AKT and MAPK pathways were activated in this process, which was demonstrated by pretreatment with TGF-β RI kinase inhibitor VI SB431542, PI3K inhibitor LY294002, p38 inhibitor SB203580, and ERK inhibitor PD98059. Furthermore, it was found that GT restrained the process of HHcy-induced EndMT via reducing oxidative stress and suppressing fore mentioned pathways with further inhibiting the activity of Snail. These results implicate that there is an untapped potential for GT as a novel therapeutic candidate for HHcy-induced EndMT through alleviating oxidative stress and canonical TGF-β/Smad and non-Smad dependent signaling pathways.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Related Concept Videos
TGF - β Signaling Pathway
Phase Transitions
Feedback Inhibition
Properties of Transition Metals
Cooperative Allosteric Transitions
Phase Transitions: Vaporization and Condensation